1. Genetic tests
  2. Susceptibility to pancreatitis induced by thiopurine immunosuppressants -Pharmacogenetics

Susceptibility to pancreatitis induced by thiopurine immunosuppressants -Pharmacogenetics

Genetic test Export to PDF
Full name:
Susceptibility to pancreatitis induced by thiopurine immunosuppressants -Pharmacogenetics
Description:

HLA-DQA1-HLA-DRB1 (rs2647087) genotyping
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Therapeutic Management
Specimen:
Fresh peripheral EDTA blood sample (before 5 pm (on Friday before 2 pm))
Method category:
Mutation screening
Method technique:
PCR based technique
Laboratory:
Centre de Génétique Humaine - CHU Sart-Tilman
RIZIV code:
565390-565401
Turnaround time (maximum):
15 days
Created:
13 Dec 2021 - 10:21
Changed:
15 Mar 2024 - 12:37
URL:
https://www.chu.ulg.ac.be/jcms/c2_24898529/fr/predisposition-aux-pancreatites-l…